Brimonidine Impurity 14, with the CAS number 934548-66-0, is a chemical compound associated with the pharmaceutical agent brimonidine, which is primarily used in the treatment of glaucoma and ocular hypertension. As an impurity, it may arise during the synthesis or degradation of brimonidine. While specific characteristics such as molecular weight, structure, and solubility may vary, impurities typically exhibit similar functional groups or structural motifs to their parent compounds. This can influence their chemical behavior, stability, and potential biological activity. Impurities like Brimonidine Impurity 14 are often characterized through techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry to ensure quality control in pharmaceutical formulations. Understanding the properties of such impurities is crucial for assessing their impact on the efficacy and safety of the primary drug. Regulatory guidelines often require detailed profiling of impurities to ensure compliance with safety standards in drug development and manufacturing.

Brimonidine Impurity 14

934548-66-0: Brimonidine Impurity 14, with the CAS number 934548-66-0, is a chemical compound associated with the pharmaceutical agent brimonidine, which is primarily used in the treatment of glaucoma and ocular hypertension. As an impurity, it may arise during the synthesis or degradation of brimonidine. While specific characteristics such as molecular weight, structure, and solubility may vary, impurities typically exhibit similar functional groups or structural motifs to their parent compounds. This can influence their chemical behavior, stability, and potential biological activity. Impurities like Brimonidine Impurity 14 are often characterized through techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry to ensure quality control in pharmaceutical formulations. Understanding the properties of such impurities is crucial for assessing their impact on the efficacy and safety of the primary drug. Regulatory guidelines often require detailed profiling of impurities to ensure compliance with safety standards in drug development and manufacturing.

CAS 934548-66-0

Brimonidine Impurity 14

Brimonidine Tartrate Impurity 8

Ref: 4Z-B-1626

8-(5-Bromo-6-quinoxalinyl)-2,3,5,6,7,8-hexahydro-5-oxoimidazo[1,2-a]pyrimidine-7-carboxylic acid

Ref: TR-B784560

Brimonidine Impurity 13

Ref: ST-EA-CP-B16026